Commercial Printing

Pfizer’s (PFE) vaccine segment should strengthen further with the recent approvals in Europe and Canada of Prevnar 13, its 13-valent pneumococcal conjugate vaccine. The vaccine is meant for the prevention of invasive pneumococcal disease (sepsis, meningitis, bacteremia, bacteremic pneumonia, and...

In a major breakthrough, Amgen (AMGN) received good news with respect to its much awaited drug Prolia (denosumab). Amgen received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for Prolia, for the treatment of osteoporosis...

Alexion Pharmaceutical’s (ALXN) Rhode Island manufacturing facility (ARIMF) should be up and running shortly as a second source of supply for the drug Soliris (eculizumab). The company recently received good news with the Committee for Medicinal Products for Human Use (CHMP) of the European...

JMP Securities today came up with their Weekly HCV Newsletter, where they reiterate their Market Outperform rating on Pharmasset, Inc. (NASDAQ: VRUS) and price target increased from $23 to $27. Pharmasset, along with Roche reported that the Data Monitoring Committee (DMC) determined that RG7128's...

Sanofi-Aventis (SNY) received good news recently with the company gaining approval from the European Commission for its atrial fibrillation drug, Multaq. The product gained approval for use in adult clinically stable patients with a history of, or current non-permanent atrial fibrillation (AF) to...

The Medicines Company (MDCO) recently received positive news in the form of a label expansion for Angiox in the EU. The European Commission granted approval for the use of Angiox as an anticoagulant in patients with heart attacks [ST-segment elevation myocardial infarction (STEMI)] undergoing...

R.R. Donnelley & Sons Company (NASDAQ: RRD) today announced that it has reached an agreement with Verizon Wireless for $100 million multi year extension. Yesterday, RRD closed at $20.88. So far in 2009, RRD climbed up over 40%. Qiao Xing Universal Telephone, Inc. (NASDAQ: XING) today entered...

Shire plc (SHPGY) continues to make progress with its Gaucher disease candidate, velaglucerase alfa. The company recently submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for velaglucerase alfa for the treatment of type I Gaucher disease. The company...

Merck (MRK) announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Elonva (corifollitropin alfa injection). Merck is seeking the drug’s approval as a treatment in controlled ovarian stimulation (COS) in combination...

Analysts at Leerink Swann maintain their "outperform" rating on Pharmasset Inc (NASDAQ: VRUS). The target price for VRUS is set to $27. VRUS has announced that the interim analysis of Phase IIb trial of nucleoside HCV polymerase inhibitor RG7128 by the data monitoring committee (DMC) was positive....

Pfizer (PFE) announced that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products advisory committee voted in favor (10 to 1) of data presented to support the safety and effectiveness of Prevnar 13, its 13-valent pneumococcal conjugate candidate vaccine. The...

R.R. Donnelley (RRD) reports Q3 EPS 54c vs Street view of 45c. RRD reports Q3 revenue $2.5 billion versus Street view of $2.4 billion.

R.R. Donnelley & Sons Company (NASDAQ: RRD) and Muller Martini entered into an agreement to develop the first fully integrated digital ink jet press and inline binding system. The system is capable of delivering books at printing speeds of 800 feet per minute and will integrate RR Donnelley’s...

R.R. Donnelley & Sons Company (NASDAQ: RRD) and HP (NYSE: HPQ) to create a technology alliance. RR Donnelley’s Research and Development Center which is expected to collaborate with the Inkjet High-speed Production Solutions unit of HP to develop new digital printing technologies. Products are...